Novo Nordisk to launch obesity drug Wegovy in Japan in February
Sign up now: Get insights on Asia's fast-moving developments
Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo
COPENHAGEN - Novo Nordisk said on Thursday it will launch its hugely popular Wegovy obesity drug in Japan on Feb. 22 next year.
Most patients in Japan will pay 30% of medical expenses for Wegovy, in line with reimbursement for other drugs, a Novo Nordisk spokesperson said. REUTERS
